Celgene Corporation was a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for cancer and immune-inflammatory diseases. Celgene was acquired by Bristol Myers Squibb (BMS) in November 2019 and its operations are now consolidated under BMS. - View it on GitHub